Oh yes, love to see it.
A COVID-19 test offering an accurate result within 30 seconds of the patient sample will be the first of its kind globally.
I also like the fact that the licence contains a buy out option. Looks like UBI management this time around are quite astute. No J&J dilemma.
2022 is gonna be a big & eventful year for UBI
Merry Christmas all!
Ann: UBI signs deal to commercialise SARS-CoV-2 N-Protein Test, page-2
Add UBI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.005(3.57%) |
Mkt cap ! $40.23M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 13.5¢ | $3.108K | 23.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 144072 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 55336 | 1 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
| UBI (ASX) Chart |